The prostaglandin D2 antagonist asapiprant ameliorates clinical severity in young hosts infected with invasive Streptococcus pneumoniae

Infection and Immunity, Ahead of Print.

Source: Infection and Immunity - April 17, 2024 Category: Infectious Diseases Authors: Manmeet BhallaSydney HerringAlexsandra LenhardJoshua R. WheelerFred AswadKlaus KlumppJustin ReboYan WangKevin WilhelmsenKristen FortneyElsa N. Bou Ghanem1Department of Microbiology and Immunology, School of Medicine, University at Buffalo, Buffalo, New Yo Source Type: research